# Prospective Collection of Therapeutic Efficacy and Safety Data in Patients with Unresectable Hepatocellular Carcinoma

> **NCT06788353** · — · RECRUITING · sponsor: **Sun Yat-sen University** · enrollment: 500 (estimated)

## Conditions studied

- Transarterial Chemoembolization
- Systemic Therapy
- Unresectable Hepatocellular Carcinoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06788353
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-03-01
- **Primary completion:** 2027-03-01
- **Final completion:** 2027-03-01
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2025-01-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06788353

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06788353, "Prospective Collection of Therapeutic Efficacy and Safety Data in Patients with Unresectable Hepatocellular Carcinoma". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT06788353. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*